LOGO
LOGO

Rogers Corp (ROG)

  • Rogers Swings To Q1 Profit 4/28/2026 5:25:41 PM
  • Rogers Corp. Q1 EPS $0.25 Vs. Loss $0.08 Year Ago 4/28/2026 4:54:23 PM
  • Genentech’s Phase III Trial Of Giredestrant Combo In ER+/HER2- Breast Cancer Misses Primary Endpoint 3/9/2026 2:16:24 AM
  • Genentech’s Phase III ALLEGORY Trial Of Gazyva In SLE Published In NEJM, Shows Significant Clinical Benefit 3/6/2026 8:48:55 AM
  • Genentech: FDA Accepts Giredestrant NDA In ESR1-Mutated, ER-Positive Advanced Breast Cancer 2/20/2026 1:16:27 AM
  • Older Articles
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap